The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-bromo-2-(1-((3S,5R)-3,5-dimethylpiperazin-1-yl)butyl)-3-ethylquinazolin-4(3H)-one ID: ALA4878042
PubChem CID: 162424450
Max Phase: Preclinical
Molecular Formula: C20H29BrN4O
Molecular Weight: 421.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCC(c1nc2c(Br)cccc2c(=O)n1CC)N1C[C@@H](C)N[C@@H](C)C1
Standard InChI: InChI=1S/C20H29BrN4O/c1-5-8-17(24-11-13(3)22-14(4)12-24)19-23-18-15(9-7-10-16(18)21)20(26)25(19)6-2/h7,9-10,13-14,17,22H,5-6,8,11-12H2,1-4H3/t13-,14+,17?
Standard InChI Key: QIOZXBYIXUDFPK-VMZNBEPHSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
28.6663 -4.6018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6652 -5.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3732 -5.8303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3714 -4.1930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0800 -4.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0789 -5.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7890 -5.8347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5048 -5.4255 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5060 -4.6003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7913 -4.1844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7867 -6.6519 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2147 -4.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9214 -4.6037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2113 -5.8361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2167 -3.3762 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9330 -2.9719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9369 -2.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2320 -1.7441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5215 -2.1498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5159 -2.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6301 -4.1969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3368 -4.6072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6471 -1.7541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8162 -1.7371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9202 -5.4295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3690 -3.3758 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
7 11 2 0
9 12 1 0
12 13 1 0
8 14 1 0
12 15 1 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
13 21 1 0
21 22 1 0
17 23 1 1
19 24 1 1
14 25 1 0
4 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 421.38Molecular Weight (Monoisotopic): 420.1525AlogP: 3.70#Rotatable Bonds: 5Polar Surface Area: 50.16Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.39CX LogP: 3.85CX LogD: 1.88Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -0.69
References 1. Fernández A, Díaz JL, García M, Rodríguez-Escrich S, Lorente A, Enrech R, Dordal A, Portillo-Salido E, Porras M, Fernández B, Reinoso RF, Vela JM, Almansa C.. (2021) Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels., 12 (11.0): [PMID:34795870 ] [10.1021/acsmedchemlett.1c00416 ]